Evaluation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
PDF
Cite
Share
Request
Original Article
VOLUME: 44 ISSUE: 3
P: 207 - 211
May 2014

Evaluation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test

Turk J Ophthalmol 2014;44(3):207-211
1. Celal Bayar Üniversitesi Tip Fakültesi, Göz Hastaliklari Anabilim Dali, Manisa, Türkiye\R\N
2. Kemal Pasa Devlet Hastanesi, Göz Hastaliklari Klinigi, Izmir, Türkiye
No information available.
No information available
Received Date: 02.08.2013
Accepted Date: 09.01.2014
PDF
Cite
Share
Request

ABSTRACT

Objectives:

The aim of this study was to evaluate subclinical multiple sclerosis (MS) patients with normal visual acuity using pattern visual evoked potentials (PVEP) test and central 30-2 threshold visual field (VF) test.

Materials and Methods:

A total of 60 patients, 30 of which had a definitive MS diagnosis and 30 who were healthy volunteers, were included in the study. The participants were divided into the following three groups: Group 1 - optic neuritis (+) MS patients, Group 2 - optic neuritis (-) MS patients, and Group 3 - control group. Using white on white perimetry, SITA FAST central 30-2 threshold VF tests and 1˚-0.3˚ PVEP measurements were performed. MD, PSD, p100 latency (ms), p100 amplitude (µV), and central 0-10˚, 0-20˚, 0-30˚, 10-20˚, 10-30˚, 20-30˚ retina sensitivities (db) were evaluated in all groups.

Results:

There was a significant difference in all parameters between Group 1 and Group 3 (p<0.05). There was a significant difference in p100 latency 1˚- 0.3˚, p100 amplitude 0.3˚, central 0-30˚, 10-30˚, 20-30˚ between Group 2 and Group 3 (p<0.05). There was no significant difference in the parameters except for p100 amplitude 1˚ between Group 1 and Group 2 (p>0.05).

Conclusion:

The evaluation of PVEP and central 30˚ VF can be used to monitor disease prognosis in subclinical MS patients.

Keywords:
Pattern visual evoked potentials, visual field, multiple sclerosis